Aadi Bioscience (FRA:3350) Net Margin % : -341.64% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Aadi Bioscience's Net Income for the three months ended in Mar. 2024 was €-16.83 Mil. Aadi Bioscience's Revenue for the three months ended in Mar. 2024 was €4.93 Mil. Therefore, Aadi Bioscience's net margin for the quarter that ended in Mar. 2024 was -341.64%.

The historical rank and industry rank for Aadi Bioscience's Net Margin % or its related term are showing as below:

FRA:3350' s Net Margin % Range Over the Past 10 Years
Min: -11009 Med: -333.87 Max: -24.84
Current: -288.72

FRA:3350's Net Margin % is ranked worse than
57.76% of 1025 companies
in the Biotechnology industry
Industry Median: -151.78 vs FRA:3350: -288.72

Aadi Bioscience Net Margin % Historical Data

The historical data trend for Aadi Bioscience's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Net Margin % Chart

Aadi Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Margin %

-24.84

-11,009.04

-397.69

-270.04

Aadi Bioscience Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial										-259.45	-289.78	-273.55	-257.18	-341.64

Competitive Comparison of Aadi Bioscience's Net Margin %

For the Biotechnology subindustry, Aadi Bioscience's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aadi Bioscience's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aadi Bioscience's Net Margin % distribution charts can be found below:

* The bar in red indicates where Aadi Bioscience's Net Margin % falls into.

Aadi Bioscience Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Aadi Bioscience's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-60.307	/	22.333
	=	-270.04 %

Aadi Bioscience's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-16.826	/	4.925
	=	-341.64 %

Aadi Bioscience (FRA:3350) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Aadi Bioscience Net Margin % Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

AADI:USA 3350:Germany

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines